Arthur Robin Williams

Arthur Robin Williams

Auto-generated profile, based on publicly available information

Arthur Robin Williams

Arthur Robin Williams (), New York State Psychiatric Institute and Columbia University, New York, New York

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2019 in The American Journal of Drug and Alcohol Abuse
Verified
Journal Article
Closed access
AWArthur Robin Williams
Arthur Robin Williams
ENEdward V. Nunes
Edward V. Nunes
ABAdam Bisaga
Adam Bisaga
FLFrances R. Levin
Frances R. Levin
MOMark Olfson
Mark Olfson
Amid worsening opioid overdose death rates, the nation continues to face a persistent addiction treatment gap limiting access to quality care for opioid use disorder (OUD). Three FDA-approved medications (methadone, buprenorphine, and extended-release naltrexone) have high quality evidence demonstrating reductions in drug use and overdose events, but most individuals with OUD do not receive them. The development of a unified public health framework, such as a Cascade of Care, could improve system level practice and treatment outcomes. In response to feedback from many stakeholders over the past year, we have expanded upon the OUD treatment cascade, first published in 2017, with additional attention to prevention stages and both individual-level and population-based services to better inform efforts at the state and federal level. The proposed cascade framework has attracted considerable interest from federal agencies including the Centers for Disease Control and Prevention (CDC) and National Institute on Drug Abuse (NIDA) along with policy-makers nationwide. We have reviewed recent literature and evidence-based interventions related to prevention, identification, and treatment of individuals with OUD and modeled updated figures from the 2016 National Survey on Drug Use and Health. Many currently employed interventions (prescriber guidelines, prescription monitoring programs, naloxone rescue) address prevention of OUD or downstream complications but not treatment of the underlying disorder itself. An OUD Cascade of Care framework could help structure local and national efforts to combat the opioid epidemic by identifying key targets, interventions, and quality indicators across populations and settings to achieve these ends. Improved data collection and reporting methodology will be imperative.

1 August 2018 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
AWArthur Robin Williams
Arthur Robin Williams
ENEdward V. Nunes
Edward V. Nunes
ABAdam Bisaga
Adam Bisaga
HPHarold A. Pincus
Harold A. Pincus
KJKimberly A. Johnson
Kimberly A. Johnson
MOMark Olfson
Mark Olfson

1 March 2016 in Health Affairs
Verified
Journal Article
Closed access
AWArthur Robin Williams
Arthur Robin Williams
MOMark Olfson
Mark Olfson
JKJune H. Kim
June H. Kim
SMSilvia S. Martins
Silvia S. Martins
HKHerbert D. Kleber
Herbert D. Kleber
Twenty-three states and the District of Columbia have passed laws implementing medical marijuana programs. The nineteen programs that were in operation as of October 2014 collectively had over one ...

10 June 2017 in Addiction
Verified
Journal Article
Closed access
PDF file
AWArthur Robin Williams
Arthur Robin Williams
JSJulian Santaella‐Tenorio
Julian Santaella‐Tenorio
CMChristine M. Mauro
Christine M. Mauro
FLFrances R. Levin
Frances R. Levin
SMSilvia S. Martins
Silvia S. Martins

1 May 2022 in Psychiatric Services
Verified
Journal Article
Closed access
JMJennifer McNeely
Jennifer McNeely
DSDaniel Schatz
Daniel Schatz
MOMark Olfson
Mark Olfson
NANoa Appleton
Noa Appleton
AWArthur Robin Williams
Arthur Robin Williams

21 September 2023 in The American Journal of Drug and Alcohol Abuse
Verified
Journal Article
Closed access
ABAmanda M. Bunting
Amanda M. Bunting
RSRiley Shearer
Riley Shearer
ALAshley Linden-Carmichael
Ashley Linden-Carmichael
AWArthur Robin Williams
Arthur Robin Williams
SCSandra D. Comer
Sandra D. Comer
JLJennifer Lorvick
Jennifer Lorvick
The rise in drug overdoses and harms associated with the use of more than one substance has led to increased use of the term "polysubstance use" among researchers, clinicians, and public health officials. However, the term retains no consistent definition across contexts. The current authors convened from disciplines including sociology, epidemiology, neuroscience, and addiction psychiatry to propose a recommended definition of polysubstance use. An iterative process considered authors' formal and informal conversations, insights from relevant symposia, talks, and conferences, as well as their own research and clinical experiences to propose the current definition. Three key concepts were identified as necessary to define polysubstance use: (1) substances involved, (2) timing, and (3) intent. Substances involved include clarifying either (1) the number and type of substances used, (2) presence of more than one substance use disorder, or (3) primary and secondary substance use. The concept of timing is recommended to use clear terms such as simultaneous, sequential, and same-day polysubstance use to describe short-term behaviors (e.g., 30-day windows). Finally, the concept of intent refers to clarifying unintentional use or exposure when possible, and greater attention to motivations of polysubstance use. These three components should be clearly defined in research on polysubstance use to improve consistency across disciplines. Consistent definitions of polysubstance use can aid in the synthesis of evidence to better address an overdose crisis that increasingly involves multiple substances.